Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00543725
What this trial is testing

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Who this might be right for
HIV InfectionsHIV-1
Tibotec Pharmaceuticals, Ireland 680
Testing effectiveness (Phase 2)Study completedNCT00054262
What this trial is testing

T900607 in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Liver Cancer
University Hospitals Seidman Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00446550
What this trial is testing

Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

Who this might be right for
Gaucher DiseaseType 1 Gaucher DiseaseGaucher Disease, Type 1
Amicus Therapeutics 19
Not applicableStudy completedNCT04002323
What this trial is testing

Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients

Who this might be right for
HIV-1-infection
University Hospital Virgen de las Nieves 88
Testing effectiveness (Phase 2)Ended earlyNCT00712491
What this trial is testing

Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Santen Inc. 20
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03863184
What this trial is testing

Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL

Who this might be right for
Mantle Cell Lymphoma
Weill Medical College of Cornell University 37
Not applicableLooking for participantsNCT06895252
What this trial is testing

Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
All India Institute of Medical Sciences 220
Testing effectiveness (Phase 2)UnknownNCT05034055
What this trial is testing

Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Yonsei University 45
Not applicableStudy completedNCT00002216
What this trial is testing

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Who this might be right for
HIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT00789633
What this trial is testing

Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
AB Science 353
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Study completedNCT02409342
What this trial is testing

Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 572
Testing effectiveness (Phase 2)UnknownNCT03579654
What this trial is testing

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 120
Post-approval studies (Phase 4)WithdrawnNCT05295394
What this trial is testing

Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study

Who this might be right for
HIV-1 Infection
Pedro Cahn
Large-scale testing (Phase 3)Study completedNCT03578640
What this trial is testing

Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4

Who this might be right for
Hepatitis C, Chronic
King Fahad Medical City 30
Large-scale testing (Phase 3)Study completedNCT03469960
What this trial is testing

Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Intergroupe Francophone de Cancerologie Thoracique 265
Testing effectiveness (Phase 2)WithdrawnNCT00895882
What this trial is testing

Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Merck Sharp & Dohme LLC
Post-approval studies (Phase 4)Ended earlyNCT03344341
What this trial is testing

A Phase IV Study in Drug-Naive Patients With T2DM in China

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 304
Post-approval studies (Phase 4)Study completedNCT05114590
What this trial is testing

Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 124
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation